Edwards Lifesciences Corp. (EW) Misses Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $90.09 +1.91%
EPS Growth %: +10.4%
Financial Fact:
Provision for income taxes: 43.8M
Today's EPS Names:
PBCO, SICP, MNSB, More
EPS Growth %: +10.4%
Financial Fact:
Provision for income taxes: 43.8M
Today's EPS Names:
PBCO, SICP, MNSB, More
Join SI Premium – FREE
Edwards Lifesciences Corp. (NYSE: EW) reported Q3 EPS of $0.38, $0.01 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $412.7 million versus the consensus estimate of $405.09 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Edwards Lifesciences faces stock risk ahead of trial results says Stifel
- FDA Approval of Edwards Lifesciences’ PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve Disease
- Orchid Island Capital (ORC) Misses Q3 EPS by 119c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
